297 related articles for article (PubMed ID: 18203321)
1. Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota.
Wilson FC; Ytterberg SR; St Sauver JL; Reed AM
J Rheumatol; 2008 Mar; 35(3):445-7. PubMed ID: 18203321
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis.
Dion E; Cherin P; Payan C; Fournet JC; Papo T; Maisonobe T; Auberton E; Chosidow O; Godeau P; Piette JC; Herson S; Grenier P
J Rheumatol; 2002 Sep; 29(9):1897-906. PubMed ID: 12233884
[TBL] [Abstract][Full Text] [Related]
3. The geoepidemiology of autoimmune muscle disease.
Prieto S; Grau JM
Autoimmun Rev; 2010 Mar; 9(5):A330-4. PubMed ID: 19906360
[TBL] [Abstract][Full Text] [Related]
4. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002.
Kitzmann AS; Pulido JS; Diehl NN; Hodge DO; Burke JP
Ophthalmology; 2008 Jan; 115(1):169-73. PubMed ID: 18166410
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and Natural History of Inclusion Body Myositis: A 40-Year Population-Based Study.
Shelly S; Mielke MM; Mandrekar J; Milone M; Ernste FC; Naddaf E; Liewluck T
Neurology; 2021 May; 96(21):e2653-e2661. PubMed ID: 33879596
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993.
Peterson LS; Nelson AM; Su WP; Mason T; O'Fallon WM; Gabriel SE
J Rheumatol; 1997 Jan; 24(1):73-80. PubMed ID: 9002014
[TBL] [Abstract][Full Text] [Related]
7. Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA.
Doran MF; Crowson CS; O'Fallon WM; Hunder GG; Gabriel SE
J Rheumatol; 2002 Aug; 29(8):1694-7. PubMed ID: 12180732
[TBL] [Abstract][Full Text] [Related]
8. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period.
Salvarani C; Crowson CS; O'Fallon WM; Hunder GG; Gabriel SE
Arthritis Rheum; 2004 Apr; 51(2):264-8. PubMed ID: 15077270
[TBL] [Abstract][Full Text] [Related]
9. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
Chahin N; Engel AG
Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus.
Limaye VS; Lester S; Blumbergs P; Roberts-Thomson PJ
Int J Rheum Dis; 2010 May; 13(2):132-7. PubMed ID: 20536597
[TBL] [Abstract][Full Text] [Related]
11. Basement membrane remodelling and segmental fibrosis in sporadic inclusion body myositis.
Doppler K; Mittelbronn M; Lindner A; Bornemann A
Neuromuscul Disord; 2009 Jun; 19(6):406-11. PubMed ID: 19473842
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis.
Needham M; Corbett A; Day T; Christiansen F; Fabian V; Mastaglia FL
J Clin Neurosci; 2008 Dec; 15(12):1350-3. PubMed ID: 18815046
[TBL] [Abstract][Full Text] [Related]
13. Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades.
Kyle RA; Therneau TM; Rajkumar SV; Larson DR; Plevak MF; Melton LJ
Cancer; 2004 Dec; 101(11):2667-74. PubMed ID: 15481060
[TBL] [Abstract][Full Text] [Related]
14. Incidence of cataract surgery from 1980 through 2004: 25-year population-based study.
Erie JC; Baratz KH; Hodge DO; Schleck CD; Burke JP
J Cataract Refract Surg; 2007 Jul; 33(7):1273-7. PubMed ID: 17586386
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and Clinical Development of Sporadic Inclusion Body Myositis and Polymyositis With Mitochondrial Pathology: A Single-Center Retrospective Analysis.
Winkler M; von Landenberg C; Kappes-Horn K; Neudecker S; Kornblum C; Reimann J
J Neuropathol Exp Neurol; 2021 Nov; 80(11):1060–1067. PubMed ID: 34643702
[TBL] [Abstract][Full Text] [Related]
16. Demographic features of Japanese patients with sporadic inclusion body myositis: a single-center referral experience.
Nakanishi H; Koike H; Matsuo K; Tanaka F; Noda T; Fujikake A; Kimura S; Katsuno M; Doyu M; Watanabe H; Sobue G
Intern Med; 2013; 52(3):333-7. PubMed ID: 23370740
[TBL] [Abstract][Full Text] [Related]
17. [The practice guideline 'Dermatomyositis, polymyositis and sporadic inclusion body myositis'].
Hoogendijk JE; Bijlsma JW; van Engelen BG; Lindeman E; van Royen-Kerkhof A; de Rie MA; de Visser M; Jennekens FG;
Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2104-11. PubMed ID: 16201600
[TBL] [Abstract][Full Text] [Related]
18. [Pathomechanism and prevalence of sporadic inclusion body myositis (sIBM)].
Suzuki N; Tateyama M; Warita H; Izumi R; Nishino I; Aoki M
Rinsho Shinkeigaku; 2011 Nov; 51(11):964-6. PubMed ID: 22277440
[TBL] [Abstract][Full Text] [Related]
19. Invasive fibroblasts: fundamental difference between sporadic inclusion body myositis and polymyositis.
Doppler K; Pantazis G; Mack A; Bornemann A
Muscle Nerve; 2014 Feb; 49(2):175-80. PubMed ID: 23649793
[TBL] [Abstract][Full Text] [Related]
20. [Histological data in inflammatory myositis].
Mikol J; Polivka M
Ann Med Interne (Paris); 2001 Nov; 152(7):465-79. PubMed ID: 11965088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]